SCHEMBL28588449

SCHEMBL28588449

NC(=O)Oc1ccc(OCc2ccnc(Nc3cnccn3)c2)c2ccccc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.45
JAK2 O60674 1/20 0.39
JAK1 P23458 1/20 0.39
TYK2 P29597 1/20 0.39
SRC P12931 3/20 0.38
GSK3A P49840 2/20 0.38
SYK P43405 1/20 0.38
HCK P08631 6/20 0.37
MAPK12 P53778 6/20 0.37
MAPK14 Q16539 6/20 0.37
NR3C2 P08235 4/20 0.37
MRGPRX4 Q96LA9 1/20 0.37
PLK4 O00444 1/20 0.37
CHEK1 O14757 1/20 0.37
PDPK1 O15530 1/20 0.37
PRKD3 O94806 1/20 0.37
MAP4K4 O95819 1/20 0.37
CHEK2 O96017 1/20 0.37
CDK1 P06493 1/20 0.37
PIM1 P11309 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17008500 0.88 LRRK2 (0.46) LRRK2JAK2JAK1TYK2SRC
SCHEMBL28573504 0.86 HCK (0.38) LRRK2SRCHCKMAPK12MAPK14
SCHEMBL31086658 0.85 LRRK2 (0.41) LRRK2JAK2JAK1TYK2SRC
SCHEMBL17008501 0.85 LRRK2 (0.41) LRRK2JAK2JAK1TYK2SRC
SCHEMBL28578481 0.84 HCK (0.39) SRCHCKMAPK12MAPK14NR3C2
SCHEMBL18567054 0.83 LRRK2 (0.41) LRRK2JAK2JAK1TYK2SRC
SCHEMBL17017643 0.83 LRRK2 (0.41) LRRK2JAK2JAK1TYK2SRC
SCHEMBL28566737 0.82 GPR52 (0.40) HCKMAPK12MAPK14MRGPRX4
SCHEMBL17008491 0.80 LMNA (0.40) LRRK2SRCHCKMAPK12MAPK14
SCHEMBL31086600 0.80 LMNA (0.40) LRRK2SRCHCKMAPK12MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113264921-A Pyrazolyl-ureas as kinase inhibitors 瑞斯比维特有限公司 2021-08-17 CN disclosed
CN-106573914-B Pyrazolyl-ureas as kinase inhibitors 瑞斯比维特有限公司 2021-05-28 CN disclosed